innoscripta SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	103.41	64.71	39.37	27.27	19.83
Revenue Growth (YoY)	59.82%	64.34%	44.36%	37.56%	-
Cost of Revenue	30.19	19.42	18.19	13.29	8.71
Gross Profit	73.22	45.29	21.19	13.98	11.11
Other Operating Expenses	9.55	7.78	5.48	4.68	3.13
Operating Expenses	9.74	7.96	5.63	4.84	3.26
Operating Income	63.48	37.32	15.56	9.15	7.86
Interest Expense	-0.05	-0.09	-0.08	-0.06	-0.21
Interest & Investment Income	0.21	0.23	0.06	0.12	0.01
Currency Exchange Gain (Loss)	-0.06	-0.05	-0.09	0.03	-0
Pretax Income	63.59	37.41	15.45	9.24	7.66
Income Tax Expense	20.98	12.32	5.18	3.15	2.57
Net Income	42.61	25.09	10.27	6.1	5.09
Net Income to Common	42.61	25.09	10.27	6.1	5.09
Net Income Growth	69.82%	144.27%	68.46%	19.88%	-
Shares Outstanding (Basic)	10	10	10	0	-
Shares Outstanding (Diluted)	10	10	10	0	-
Shares Change (YoY)	-	-	39900.00%	-	-
EPS (Basic)	4.26	2.51	1.03	243.89	-
EPS (Diluted)	4.26	2.51	1.03	243.89	-
EPS Growth	69.82%	144.27%	-99.58%	-	-
Free Cash Flow	40.64	20	5.15	8.56	-0.59
Free Cash Flow Per Share	4.06	2.00	0.52	342.41	-
Dividend Per Share	4.000	2.400	1.600	200.000	-
Dividend Growth	66.67%	50.00%	-99.20%	-	-
Gross Margin	70.80%	69.99%	53.81%	51.27%	56.05%
Operating Margin	61.38%	57.68%	39.52%	33.54%	39.63%
Profit Margin	41.20%	38.78%	26.09%	22.36%	25.65%
Free Cash Flow Margin	39.30%	30.91%	13.08%	31.39%	-2.98%
EBITDA	63.67	37.51	15.71	9.3	7.98
EBITDA Margin	61.57%	57.97%	39.91%	34.10%	40.25%
D&A For EBITDA	0.2	0.18	0.15	0.15	0.12
EBIT	63.48	37.32	15.56	9.15	7.86
EBIT Margin	61.38%	57.68%	39.52%	33.54%	39.63%
Effective Tax Rate	32.99%	32.94%	33.52%	34.04%	33.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.